Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0164
NEWS & VIEWS
|
Standard and new treatment strategy to prevent melanoma recurrence. |
Prof. Odysseas Zoras, M.D, PhD.
|
Affiliation: Professor Odysseas Zoras, Department of General Surgery, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Crete, Greece.
E-mail: ozoras@med.uoc.gr |
Since there is no abstract available we provide the first paragraph.
Cancer biology and genetics advances have provided highlights in an improvement in understanding why some patients with melanoma recur to current treatment modality. One possible explanation is the presence of mutations in the BRAF gene. However, molecular mechanisms underlying recurrence are much more complex and sophisticated research is needed to understand the full story of treatment failure and patient's death [1, 2].
(Citation: Gastric & Breast Cancer 2011; 10(2):
100-102)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 15 March 2011 |
|
